NEFL and amyotrophic lateral sclerosis: Moreover, a recent study showed that the cerebrospinal fluid (CSF), serum, and plasma levels of neurofilament light chain (NfL)—a marker of axonal loss—were markedly higher in ALS patients as compared to the healthy controls.